# Variable Legend

This document provides a detailed legend for variables present in the `flu_fighters.csv` dataset. Variables are grouped by analytical category or biological measurement type.

<details>

<summary>Blood Gene Expression (Baseline and Fold Change) ğŸ©¸ğŸ§ª</summary>

**Variables:**

* `blood_baseline_go.*`

**Description:**

* These variables represent the expression levels of genes associated with specific Gene Ontology (GO) terms in blood samples.
* **Baseline Measurements (`blood_baseline_go.*`):** Indicate the initial gene expression levels before vaccination.

- **Gene Ontology (GO):** A standardized system that classifies genes based on their biological processes, cellular components, and molecular functions.

</details>

<details>

<summary>Nasal Gene Expression (Baseline and Fold Change) ğŸ‘ƒğŸ§ª</summary>

**Variables:**

* `nasal_baseline_go.*`

**Description:**

* Similar to the blood gene expression variables, these represent gene expression levels in nasal samples.
* **Importance:** Nasal mucosa is a primary site for respiratory infections like influenza, making nasal gene expression critical for understanding mucosal immunity.

</details>

<details>

<summary>Hemagglutination Inhibition (HAI) Responses ğŸ¦ ğŸ’‰</summary>

**Variables:**

* `h1_hai_v0_gmt`, `h1_hai_v21_gmt`, `h3_hai_v0_gmt`, `h3_hai_v21_gmt`, `b_hai_v0_gmt`, `b_hai_v21_gmt`
* `h1_hai_gmt_fold_change`, `h3_hai_gmt_fold_change`, `b_hai_gmt_fold_change`

**Description:**

* **HAI Assay:** Measures the ability of antibodies in the serum to prevent the agglutination of red blood cells by the influenza virus, indicating neutralizing antibody levels.
* **Viruses:**
  * `h1_`: HAI against H1N1
  * `h3_`: HAI against H3N2
  * `b_`: HAI against Influenza B
* **Timepoints:**
  * `_v0_gmt`: Geometric Mean Titer (across all three vaccine influenza strains) at baseline (pre-vaccination).
  * `_v21_gmt`: Geometric Mean Titer (across all three vaccine influenza strains) 21 days post-vaccination.
* **Interpretation:**
  * **Seroconversion:** An increase in HAI titer of more than 4-fold post-vaccination is considered seroconversion, and is associated with the 50% reduction in influenza disease severity.
  * **Seropositivity:** An HAI titer above 40 is considered seropositive, suggesting protective immunity.
* **Assay Procedure:**
  * Patient serum is mixed with standardized virus amounts.
  * Red blood cells are added; if antibodies are present, they inhibit hemagglutination.

</details>

<details>

<summary>Immunoglobulin A (IgA) Responses ğŸ§«ğŸ›¡ï¸</summary>

**Variables:**

* `ph1n1_ha_iga_v0`, `ph1n1_ha_iga_v21`, `h3n2_ha_iga_v0`, `h3n2_ha_iga_v21`, `bvic_ha_iga_v0`, `bvic_ha_iga_v21`
* `ph1n1_na_iga_v0`, `ph1n1_na_iga_v21`, `h3n2_na_iga_v0`, `h3n2_na_iga_v21`, `bvic_na_iga_v0`, `bvic_na_iga_v21`
* `ph1n1_ha_iga_fold_change`, `h3n2_ha_iga_fold_change`, `bvic_ha_iga_fold_change`
* `max_iga_responder`

**Description:**

* **IgA Antibodies:** Play a crucial role in mucosal immunity by neutralizing pathogens at entry points.
* **Measurements:**
  * Levels of IgA specific to hemagglutinin (HA) and neuraminidase (NA) antigens of influenza viruses.
* **Timepoints:**
  * `_v0`: Baseline levels.
  * `_v21`: Levels 21 days post-vaccination.
* **Fold Change:** Indicates the increase in IgA levels post-vaccination.

</details>

<details>

<summary>T Cell Responses (CD4âº and CD8âº Cells) ğŸ¦ ğŸ”¬</summary>

**Variables:**

* `h1_v0_cd4_ifng`, `h1_v21_cd4_ifng`, `h1_v0_cd4_il2`, `h1_v21_cd4_il2`
* Similar variables for `cd8` cells and other influenza strains (`h3`, `hmnp`, `hab`, `bmnp`)
* Fold change variables like `h1_cd4_ifng_fold_change`
* `max_mnp_cd4_responder`, `max_mnp_cd8_responder`

**Description:**

* **Function:** Measure cytokine production by T cells in response to influenza antigens.
* **Cytokines:**
  * **IFN-Î³ (Interferon gamma):** Indicates Th1 response, important for antiviral immunity.
  * **IL-2 (Interleukin-2):** Supports T cell proliferation.
* **Cell Types:**
  * **CD4âº T Cells:** Helper cells that orchestrate immune responses.
  * **CD8âº T Cells:** Cytotoxic cells that kill infected cells.
* **Assay Procedure:**
  * Cells are stimulated with antigens and cytokine production is measured via flow cytometry or ELISPOT.

</details>

<details>

<summary> Influenza Virus Protein Microarray (IVPM) Responses ğŸ¦ ğŸ§¬</summary>

**Variables:**

* `nc99_ivpm_h1_v0`, `nc99_ivpm_h1_v21`, `mich15_h1_ivpm_v0`, etc.
* Fold change variables like `nc99_ivpm_h1_fold_change`

**Description:**

* **IVPM Assay:** Detects antibody responses to multiple influenza strains simultaneously using microarray technology.
* **Purpose:** Evaluates the breadth of the immune response.

</details>

<details>

<summary>Antibody-Dependent Cellular Cytotoxicity (ADCC) and Secretory IgA (SIgA) Responses ğŸ›¡ï¸ğŸ”¬</summary>

**Variables:**

* `ch6_adcc_auc_v0`, `ch6_adcc_auc_v21`, `ch6_adcc_auc_fold_change`
* `ch6_siga_v0`, `ch6_siga_v21`, `ch6_siga_fold_change`
* Similar variables for `ch7`

**Description:**

* **ADCC:**
  * **Function:** Assesses the ability of antibodies to recruit natural killer (NK) cells to destroy infected cells.
  * **Measurement:** Area Under the Curve (AUC) represents the overall ADCC activity.
* **SIgA:**
  * **Function:** Secretory IgA antibodies protect mucosal surfaces by neutralizing pathogens.

</details>

<details>

<summary>Neuraminidase binding assay titers ğŸ§ªğŸ§¬</summary>

**Variables:**

* `n1_titer_v0`, `n1_titer_v21`, `n2_titer_v0`, `n2_titer_v21`
* `n1_titer_fold_change`, `n2_titer_fold_change`

**Description:**

* **NI Assay:** Measures antibodies that bind neuraminidase (NA) from group 1 (H1N1) and group 2 (H3N2) flu viruses.
* **Importance:** NA antibodies have cross-reactivity.

</details>

<details>

<summary>Viral Shedding ğŸŒ¬ï¸ğŸ¦ </summary>

**Variables:**

* `h1_v2_shed`, `h3_v2_shed`, `b_v2_shed`
* `h1_v7_shed`, `h3_v7_shed`, `b_v7_shed`

**Description:**

* **Definition:** Detection of virus in nasal swabs post-vaccination.
* **Timepoints:**
  * `_v2_shed`: Viral shedding at day 2.
  * `_v7_shed`: Viral shedding at day 7.
* **Significance:** Indicates active viral replication and potential transmissibility.

</details>

<details>

<summary>Demographics and Baseline Characteristics ğŸ‘¤ğŸ“‹</summary>

**Variables:**

* `year`, `sex`, `age_months`, `z_score_continuous`

**Description:**

* **Year:** Study year or participant's birth year.
* **Sex:** Male or Female.
* **Age in Months:** Participant's age at the time of study.
* **Z-Score:** Standardized score indicating nutritional status or growth parameters.

</details>

<details>

<summary>Seropositivity and Seroconversion Status ğŸ›¡ï¸ğŸ§ª</summary>

**Variables:**

* `h1_v0_seropositive`, `h3_v0_seropositive`, `b_v0_seropositive`

**Description:**

* **Seropositivity:** Indicates the presence of protective antibody levels at baseline.
* **Criteria:** HAI titer above 40 is considered seropositive.
* **Implication:** Participants already have some immunity prior to vaccination.

</details>

<details>

<summary>Monocyte and Dendritic Cell Counts ğŸ§ªğŸ”¬</summary>

**Variables:**

* **Myeloid Dendritic Cells (mDCs):**
  * `v0_mdcs`
* **Plasmacytoid Dendritic Cells (pDCs):**
  * `v0_pdcs`
* **Monocytes:**
  * `v0_classical_monocytes`
  * `v0_nonclassical_monocytes`
  * `v0_intermediate_monocytes`

**Description:**

* **Function:** Dendritic cells and monocytes are crucial for antigen presentation and initiating immune responses.
* **Timepoints:** Counts at baseline

</details>

<details>

<summary>T Follicular Helper (Tfh) Cells ğŸ¦ ğŸ”¬</summary>

**Variables:**

* `tfh_cxcr3_icos_pd1_v0`

**Description:**

* **Role:** Tfh cells assist B cells in producing high-affinity antibodies.
* **Markers:**
  * **CXCR3, ICOS, PD-1:** Surface proteins used to identify activated Tfh cells.
* **Significance:** Increased Tfh cells correlate with better antibody responses.

</details>

<details>

<summary>Baseline Respiratory Virus and Pneumococcus Detection ğŸ¦ ğŸ©º</summary>

**Variables:**

* `v0_resp_virus_positive`
* `v0_pneumo_ng_log10copies_ul`

**Description:**

* **Respiratory Virus Positive:** Indicates the presence of 14 respiratory viruses at baseline, which could affect immune responses.
* **Pneumococcus Load:** Quantifies nasal carriage of _Streptococcus pneumoniae_.

</details>

<details>

<summary>Fold Change in Immune Responses ğŸ“ˆğŸ§ª</summary>

**Variables:**

* Variables ending with `_fold_change` for various assays (e.g., `h1_cd4_ifng_fold_change`)

**Description:**

* **Calculation:** Post-vaccination value divided by baseline value.
* **Purpose:** Assesses the magnitude of the immune response induced by vaccination.

</details>

